| Literature DB >> 16882538 |
Sabine J Regel1, Sonja Negovetic, Martin Röösli, Veronica Berdiñas, Jürgen Schuderer, Anke Huss, Urs Lott, Niels Kuster, Peter Achermann.
Abstract
BACKGROUND: Radio-frequency electromagnetic fields (RF EMF) of mobile communication systems are widespread in the living environment, yet their effects on humans are uncertain despite a growing body of literature.Entities:
Mesh:
Year: 2006 PMID: 16882538 PMCID: PMC1552030 DOI: 10.1289/ehp.8934
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Sketch of the exposure chamber. Walls were covered by pyramidal RF absorbers and nonreflecting curtains. The ceiling was covered by flat absorbers. Antenna, E-field probe, furniture, screen, keyboard, response box, web camera, inner dimensions (w, width; h, height; l, length), and position of the antenna are indicated.
Results of applied questionnaires (mean scores ± SD; n = 33 sensitive and n = 84 nonsensitive subjects).
| Outcome | Group | Sham | 1 V/m | 10 V/m | Cond. | Cond. |
|---|---|---|---|---|---|---|
| QCDdiff | Sensitive | 0.30 ± 0.83 | 0.24 ± 0.99 | 0.24 ± 0.95 | 0.88 | 0.95 |
| Nonsensitive | 0.05 ± 0.73 | –0.04 ± 0.59 | 0.02 ± 0.55 | 0.93 | 0.95 | |
| QCDpost | Sensitive | 2.57 ± 1.06 | 2.65 ± 1.22 | 2.61 ± 0.97 | 0.97 | 0.96 |
| Nonsensitive | 2.19 ± 0.76 | 2.05 ± 0.80 | 2.13 ± 0.78 | 0.97 | 0.89 | |
| TNO-Q | Sensitive | 10.53 ± 9.51 | 9.61 ± 8.96 | 9.79 ± 8.38 | 0.84 | 0.65 |
| Nonsensitive | 5.23 ± 5.09 | 4.45 ± 4.92 | 4.96 ± 5.08 | 0.78 | 0.92 | |
| Field perception | Sensitive | 26.0 ± 31.9 | 31.2 ± 33.7 | 29.4 ± 29.7 | 0.89 | 0.67 |
| Nonsensitive | 12.9 ± 22.8 | 5.7 ± 13.1 | 12.2 ± 23.2 | 0.24 | 0.33 |
A difference score > 0 in the QCDdiff corresponds to a degradation in current well-being during the experiment. In the QCDpost and the TNO-Q, higher scores refer to a lower well-being. We report only p-values of condition (Cond.) (for details, see “Materials and Methods”).
Adjusted for order.
Adjusted for order, age, sex, BMI, caffeine intake, medication, (pre-)menstrual complaints, sleep quality, and suffering from a cold.
Results of cognitive performance (mean speed ± SD).
| Outcome | Group | Session | Sham | 1 V/m | 10 V/m | Cond. | Cond. × session | Cond. | Cond. × session |
|---|---|---|---|---|---|---|---|---|---|
| SRT | Sensitives | 1 | 3.86 ± 0.52 | 3.78 ± 0.44 | 3.84 ± 0.48 | 0.09 | 0.27 | 0.07 | 0.27 |
| 2 | 3.73 ± 0.56 | 3.65 ± 0.43 | 3.78 ± 0.47 | ||||||
| Nonsensitives | 1 | 3.85 ± 0.37 | 3.85 ± 0.38 | 3.84 ± 0.43 | 0.59 | 0.51 | 0.37 | 0.50 | |
| 2 | 3.70 ± 0.44 | 3.70 ± 0.49 | 3.68 ± 0.41 | ||||||
| CRT | Sensitives | 1 | 2.37 ± 0.28 | 2.33 ± 0.25 | 2.33 ± 0.28 | 0.03 | 0.01 | 0.02 | 0.01 |
| 2 | 2.25 ± 0.30 | 2.20 ± 0.27 | 2.31 ± 0.22 | ||||||
| Nonsensitives | 1 | 2.27 ± 0.26 | 2.27 ± 0.27 | 2.24 ± 0.25 | 0.13 | 0.25 | 0.08 | 0.24 | |
| 2 | 2.22 ± 0.27 | 2.21 ± 0.27 | 2.21 ± 0.25 | ||||||
| N-back | |||||||||
| 1-Back | Sensitives | 1 | 2.15 ± 0.56 | 2.12 ± 0.55 | 2.13 ± 0.55 | 0.90 | 0.67 | 0.93 | 0.67 |
| 2 | 2.27 ± 0.57 | 2.29 ± 0.54 | 2.29 ± 0.49 | ||||||
| Nonsensitives | 1 | 2.12 ± 0.44 | 2.12 ± 0.48 | 2.10 ± 0.42 | 0.57 | 0.97 | 0.46 | 0.98 | |
| 2 | 2.26 ± 0.44 | 2.28 ± 0.48 | 2.24 ± 0.43 | ||||||
| 2-Back | Sensitives | 1 | 1.59 ± 0.46 | 1.53 ± 0.44 | 1.53 ± 0.35 | 0.61 | 0.44 | 0.50 | 0.43 |
| 2 | 1.70 ± 0.49 | 1.71 ± 0.53 | 1.71 ± 0.47 | ||||||
| Nonsensitives | 1 | 1.63 ± 0.39 | 1.58 ± 0.39 | 1.60 ± 0.38 | 0.44 | 0.52 | 0.37 | 0.52 | |
| 2 | 1.74 ± 0.42 | 1.74 ± 0.43 | 1.72 ± 0.39 | ||||||
| 3-Back | Sensitives | 1 | 1.48 ± 0.40 | 1.48 ± 0.46 | 1.48 ± 0.39 | 0.57 | 0.52 | 0.39 | 0.51 |
| 2 | 1.56 ± 0.42 | 1.60 ± 0.51 | 1.54 ± 0.37 | ||||||
| Nonsensitives | 1 | 1.56 ± 0.44 | 1.57 ± 0.51 | 1.51 ± 0.36 | 0.59 | 0.11 | 0.64 | 0.11 | |
| 2 | 1.70 ± 0.55 | 1.64 ± 0.50 | 1.70 ± 0.49 | ||||||
| VSAT | Sensitives | 1 | 1.74 ± 0.33 | 1.72 ± 0.31 | 1.75 ± 0.31 | 0.28 | 0.94 | 0.22 | 0.94 |
| 2 | 1.85 ± 0.29 | 1.85 ± 0.31 | 1.87 ± 0.28 | ||||||
| Nonsensitives | 1 | 1.69 ± 0.34 | 1.69 ± 0.33 | 1.68 ± 0.29 | 0.64 | 0.70 | 0.50 | 0.71 | |
| 2 | 1.79 ± 0.32 | 1.83 ± 0.36 | 1.79 ± 0.31 | ||||||
Mean speed ± SD [1/reaction time (1/sec); n = 33 sensitive and n = 84 nonsensitive subjects] in the two sessions (first and second half of exposure) in the SRT CRT, N-back, and VSAT. We report only p-values of condition (Cond.) and of the interaction condition × session (for details, see “Materials and Methods”). Statistical analysis is based on data of all subjects. Because of a missing session in some subjects, mean values are based on subjects who completed both sessions in each condition (n = at least 32 sensitive and n = at least 77 nonsensitive subjects).
Adjusted for order.
p-Values not adjusted for testing multiple end points.
Adjusted for order, age, sex, BMI, caffeine intake, medication, (pre-)menstrual complaints, sleep quality, and suffering from a cold.
Correlations between perceived E-field strength and real exposure condition (sham, 1 V/m, 10 V/m).
| Correlation between perceived and real field | |||||
|---|---|---|---|---|---|
| Positive | Negative | Zero | |||
| All | 88 | 39 | 40 | 9 | 1 |
| Sensitive | 31 | 17 | 13 | 1 | 0.58 |
| Nonsensitive | 57 | 22 | 27 | 8 | 0.56 |
Two sensitive and 27 nonsensitive subjects perceived no field in all three conditions and were omitted from the analysis.
Sign test.
Averaged SAR for whole body and brain and peak spatial averaged SAR for whole body, brain, skin, and muscle for an E-field strength of 1 V/m.
| Tissue | SAR [average ± SD (μW/kg)] | Uncertainty [95% CI (%)] |
|---|---|---|
| Whole body | 6.2 ± 1.8 | 41 |
| 10 g (peak spatial) | 150 ± 49 | 39 |
| 1 g (peak spatial) | 320 ± 130 | 41 |
| Brain | 11 ± 2.4 | 48 |
| 10 g (peak spatial) | 45 ± 13 | 45 |
| 1 g (peak spatial) | 73 ± 16 | 44 |
| Skin | ||
| 10 g (peak spatial) | 230 ± 48 | 50 |
| 1 g (peak spatial) | 380 ± 76 | 39 |
| Muscle | ||
| 10 g (peak spatial) | 120 ± 31 | 48 |
| √1 g (peak spatial) | 190 ± 62 | 39 |
Data are, for an E-field strength of 1 V/m, averaged SAR values ± SD of variations and the absolute uncertainty [95% confidence interval (CI)] for whole body and brain, and peak spatial averaged SAR for whole body, brain, skin, and muscle (1 and 10 g) of an average male (80 kg). To obtain SAR values at a field strength of 10 V/m, SAR values in the table have to be multiplied by 100.
Figure 2SAR distribution on the surface of a male (80 kg) in a sitting position (top view): 0 dB corresponds to 0.05 W/kg for an E-field strength of 1 V/m. The orientation of the E-field (), the magnetic field (), and the propagation direction () of the EMF are indicated.
Ratios of averaged SAR values between various organs or tissue and whole body and between left and right sides.
| Organ/tissue | Ratio organ or tissue:whole body | Ratio left:right |
|---|---|---|
| Gray matter (left hemisphere) | 3.5 | 2.9 |
| White matter (left hemisphere) | 2.0 | 2.6 |
| Cerebellum | 0.52 | — |
| Hippocampus (left hemisphere) | 0.84 | 1.6 |
| Hypothalamus (left hemisphere) | 0.52 | 1.9 |
| Thalamus (left hemisphere) | 0.64 | 0.81 |
| Parotid gland | 4.6 | — |
| Ear pinna (left) | 17 | 18 |
| Eyeball (left) | 5.6 | 8.8 |
Data are ratios, for an average male (80 kg), between organ or tissue averaged SAR values and the whole-body averaged SAR value (6.2 μW/kg at 1 V/m) for regions of the brain, ear, eye and throat and the ratio between the averaged SAR values of the left and right sides. The parotid gland is the largest of the salivary glands and was looked at specifically.